Mariska Hargitay has extended her starring run in the Broadway play “Every Brilliant Thing” by one week [2].
The extension reflects the production's current momentum at the Hudson Theatre in New York City. As a high-profile star, Hargitay's presence often drives ticket sales and public interest in limited Broadway engagements.
Producers Second Half Productions, Seaview, and Gavin Kalin Productions said the performance schedule changed [1]. The production is now set to run from May 26 through July 5, 2026 [1].
This additional week of performances allows the production to capitalize on the actress's availability and the play's reception. The Hudson Theatre serves as the venue for the engagement, hosting the production through the updated closing date [4].
The decision to extend the run by one week [2] ensures more opportunities for audiences to see Hargitay in the role before the production concludes its current residency. The updated schedule remains centered around the summer window in New York City [1].
“Mariska Hargitay has extended her starring run in the Broadway play “Every Brilliant Thing” by one week.”
Limited-run Broadway engagements often use short extensions to maximize revenue and accommodate demand without committing to a full open-ended run. By extending Hargitay's tenure by one week, the producers are leveraging her star power to ensure a high-capacity closing period.
